Search Results
Results found for "Caldan Therapeutics"
- 📰 GPCR Weekly News, February 6 to 12, 2023
IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic cancer models Addex Therapeutics in ADX71149 Epilepsy Phase 2 Study Part 1 IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics
- 📰 GPCR Weekly News, July 31 to August 6, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd. Additional Chf 2.7 Million From Indivior In Extended Substance Use Disorder Research Collaboration Addex Therapeutics
- Chronic itch: emerging treatments following new research concepts
itch processing, the numerous mediators and receptors involved has led to a large variety of possible therapeutic
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company unlocking the therapeutic
- 📰 GPCR Weekly News, November 13 to 19, 2023
identification of potential agonists of FFAR4 for type 2 diabetes mellitus therapy Industry News OMass Therapeutics (ANDA) Litigation PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Separate effect size from time: Use allosteric modulators to expand therapeutic index and reduce overdose Why It Matters In the CNS, where receptor localization and real-time signaling shape therapeutic outcomes
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
interacting with the Glucagon receptor (GCGR), which constitutes an important target for diabetes and obesity therapeutics
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic marker and therapeutic
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
Understanding these processes has important implications for understanding the therapeutic intervention
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
These therapeutic strategies could greatly impact the treatment of CVD with unprecedented benefits which
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
years to uncover the mechanisms of disease before they can even dare to contemplate the development of therapeutic
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
How Structural Biology Informs the Development of Drugs Targeting G Protein-Coupled Receptors ARTICA THERAPEUTICS GPCR Jobs NEW GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- GPCR Signaling and mTORC1 Regulation
of mTOR complex 1 (mTORC1) is typically observed in human disease and continues to be an important therapeutic
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
These insights will facilitate further development of therapeutic agents targeting the DOR.Communicated
- A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation
These findings indicate the potential of inhibiting MC4R homodimerization as a therapeutic target to
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
Currently, there is no cure for RP, and the therapeutic options are limited.
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Industry News Design Pharmaceuticals has a new website Confo Therapeutics Announces Global Licensing Antiverse raises €2.8M for its computational antibody drug discovery platform Antiverse identifies therapeutic
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
theoretically offer several advantages compared to orthosteric ligands when considered as potential therapeutic other GPCR-regulated systems such as free fatty acid receptors (FFARs), now regarded as targets for therapeutic
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
It is a therapeutic target because it plays a role in thermogenesis, lipolysis, and bladder relaxation
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Matt Barnes appointed President of Heptares Therapeutics Ltd., and Head of UK R&D Tokyo, Japan and Cambridge
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
crucial for understanding how drugs can selectively target different receptor conformations to achieve therapeutic
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
consequently activated signaling pathways, and also may shed light on the development of more effective new therapeutics
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
their appearance on the (illicit) drug market, e.g. as new psychoactive substances, their potential therapeutic
- Combined docking and machine learning identify key molecular determinants of ligand pharmacological
September 2022 "G protein‐coupled receptors (GPCRs) are valuable therapeutic targets for many diseases
- Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
PTH-related protein (PTHrP) ligands and analogues for their pharmacologic activities and potential therapeutic
- Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
kinetic studies "G protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic
- Precise druggability of the PTH type 1 receptor
PTHR signaling that could be extended to GPCRs to expedite discoveries of small molecules as novel therapeutic
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Our results suggest that strategies to selectively target OGR1 expression may represent a novel therapeutic
- Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
2022 "The glucagon-like peptide-1 receptor (GLP-1R) plays a key role in metabolism and is an important therapeutic


